---
layout: minimal-medicine
title: Teneligliptin + Metformin + Voglibose
---

# Teneligliptin + Metformin + Voglibose
### Generic Name
Teneligliptin + Metformin + Voglibose

**Note:**  A fixed-dose combination of teneligliptin, metformin, and voglibose is not a standard, widely available formulation.  The information below addresses each component individually, explaining their combined potential use in managing type 2 diabetes.  It is crucial to consult a healthcare professional for personalized treatment and dosage information as this combination would need to be prescribed individually by a physician.  There are many variations in metformin dose, as well as different strengths of teneligliptin and voglibose available.

### Usage

This combination of medications is potentially used to manage type 2 diabetes mellitus. Let's examine each drug's role:

* **Teneligliptin:** This is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the release of insulin when blood sugar levels are high and decreasing the production of glucagon (a hormone that raises blood sugar) when blood sugar is low. This helps to improve blood glucose control.

* **Metformin:** This is a biguanide. It works primarily by reducing glucose production in the liver and increasing insulin sensitivity in muscles.  It also has a minor effect on improving glucose absorption in the gut.  Metformin is a cornerstone of type 2 diabetes treatment.

* **Voglibose:** This is an alpha-glucosidase inhibitor. It works by slowing down the breakdown of carbohydrates in the small intestine. This leads to a slower and more gradual rise in blood sugar after meals.

The combined use of these three medications aims to improve blood glucose control through multiple mechanisms.  This approach might be considered for individuals whose blood sugar is not adequately controlled with one or two of these medications alone.  It addresses different aspects of glucose metabolism.

### Dosage

**Dosage for each component must be determined by a physician based on the individual's health status and response to therapy.**  There is no standard fixed combination.  The dosages below are examples, not prescriptions.

* **Teneligliptin:**  Oral administration, dosages ranging from 10mg to 20mg per day, usually taken once daily.

* **Metformin:** Oral administration, dosages vary greatly depending on individual needs and tolerance.  They start low and gradually increase.  Common dosages range from 500mg to 2000mg per day, often split into multiple doses. Extended-release formulations exist to reduce side effects.

* **Voglibose:** Oral administration, usually taken with the first bite of each main meal.  Dosages commonly range from 0.3mg to 1.2mg per day, often split across meals.


There are no IV formulations for teneligliptin or voglibose; metformin is only available orally.  Dosage adjustments may be necessary based on renal function (especially crucial for metformin) and other health factors.

### Side Effects

**Teneligliptin:**

* Common: Upper respiratory tract infection, headache, hypoglycemia (low blood sugar, especially if combined with other diabetes medications), nasopharyngitis.
* Less common but serious:  Pancreatitis (inflammation of the pancreas â€“ seek immediate medical attention).  Allergic reactions.

**Metformin:**

* Common: Gastrointestinal upset (nausea, diarrhea, vomiting), metallic taste.
* Less common but serious: Lactic acidosis (a rare but potentially fatal complication, especially in individuals with kidney problems or liver disease).  Vitamin B12 deficiency.

**Voglibose:**

* Common: Diarrhea, abdominal discomfort, flatulence.
* Less common but serious:  Severe hypoglycemia (especially when combined with insulin or other hypoglycemic agents).  Hepatotoxicity (rare liver damage).

**Note:** This is not an exhaustive list. Consult a healthcare professional if you experience any adverse effects.

### How it Works

As described in the Usage section, each medication works through a distinct mechanism to control blood sugar:  Teneligliptin enhances insulin release and suppresses glucagon; Metformin reduces liver glucose production and improves insulin sensitivity; and Voglibose slows carbohydrate digestion. Their combined action offers a multifaceted approach to managing type 2 diabetes.

### Precautions

* **Contraindications:**  Metformin is contraindicated in individuals with severe kidney disease, liver disease, or heart failure.  Caution is advised for those with a history of lactic acidosis.  Voglibose should be used cautiously in individuals with intestinal disorders.

* **Drug Interactions:**  Metformin can interact with many medications.  It's vital to inform your doctor of all medications being taken.

* **Pregnancy and Breastfeeding:**  The use of these medications during pregnancy and breastfeeding should be carefully assessed by a doctor; individual risk/benefit assessment is critical.

* **Older Adults:**  Older adults are generally more susceptible to adverse effects of these drugs, particularly the gastrointestinal side effects of metformin and the risk of lactic acidosis and hypoglycemia. Close monitoring is needed.

* **Children:**  These medications are generally not used in children unless specifically recommended by a pediatric endocrinologist.


### FAQs

* **Q: Can I take this combination without a doctor's prescription?**  A: No.  This combination requires individualized assessment and prescription by a healthcare professional.  Self-medicating can be dangerous.

* **Q: How should I store these medications?**  A: Store according to the instructions on each medication's packaging. Typically, this involves keeping them in a cool, dry place away from direct sunlight and moisture.

* **Q: What should I do if I miss a dose?** A: Follow the advice given in the patient information leaflet provided with each medication. Generally, don't take a double dose to compensate for a missed one.

* **Q:  Are there any long-term risks associated with this medication combination?** A:  Long-term use can have various risks, including the development of vitamin B12 deficiency (metformin), and the possibility of pancreatitis (tenagliptin).  Regular monitoring of blood sugar, kidney function (especially with metformin), and liver function (with voglibose) is important.

**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice. Always consult a healthcare professional for diagnosis, treatment, and personalized recommendations related to your health.  The information above is not intended to endorse any specific drug or combination thereof.  Always follow your physician's advice on your prescribed medications.
